These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 27455255

  • 1. Comparative Analysis for the Presence of IgG Anti-Aquaporin-1 in Patients with NMO-Spectrum Disorders.
    Sánchez Gomar I, Díaz Sánchez M, Uclés Sánchez AJ, Casado Chocán JL, Suárez-Luna N, Ramírez-Lorca R, Villadiego J, Toledo-Aral JJ, Echevarría M.
    Int J Mol Sci; 2016 Jul 23; 17(8):. PubMed ID: 27455255
    [Abstract] [Full Text] [Related]

  • 2. Anti-aquaporin-1 autoantibodies in patients with neuromyelitis optica spectrum disorders.
    Tzartos JS, Stergiou C, Kilidireas K, Zisimopoulou P, Thomaidis T, Tzartos SJ.
    PLoS One; 2013 Jul 23; 8(9):e74773. PubMed ID: 24086369
    [Abstract] [Full Text] [Related]

  • 3. Neuromyelitis optica spectrum disorders with antibodies to myelin oligodendrocyte glycoprotein or aquaporin-4: Clinical and paraclinical characteristics in Algerian patients.
    Bouzar M, Daoudi S, Hattab S, Bouzar AA, Deiva K, Wildemann B, Reindl M, Jarius S.
    J Neurol Sci; 2017 Oct 15; 381():240-244. PubMed ID: 28991690
    [Abstract] [Full Text] [Related]

  • 4. Development of a cell-based assay for the detection of anti-aquaporin 1 antibodies in neuromyelitis optica spectrum disorders.
    Long Y, Zheng Y, Shan F, Chen M, Fan Y, Zhang B, Gao C, Gao Q, Yang N.
    J Neuroimmunol; 2014 Aug 15; 273(1-2):103-10. PubMed ID: 24972850
    [Abstract] [Full Text] [Related]

  • 5. Short myelitis lesions in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorders.
    Flanagan EP, Weinshenker BG, Krecke KN, Lennon VA, Lucchinetti CF, McKeon A, Wingerchuk DM, Shuster EA, Jiao Y, Horta ES, Pittock SJ.
    JAMA Neurol; 2015 Jan 15; 72(1):81-7. PubMed ID: 25384099
    [Abstract] [Full Text] [Related]

  • 6. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives.
    Jasiak-Zatonska M, Kalinowska-Lyszczarz A, Michalak S, Kozubski W.
    Int J Mol Sci; 2016 Mar 02; 17(3):273. PubMed ID: 26950113
    [Abstract] [Full Text] [Related]

  • 7. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status.
    Yoshimura S, Isobe N, Matsushita T, Yonekawa T, Masaki K, Sato S, Kawano Y, Kira J, South Japan Multiple Sclerosis Genetics Consortium.
    J Neurol Neurosurg Psychiatry; 2013 Jan 02; 84(1):29-34. PubMed ID: 23038741
    [Abstract] [Full Text] [Related]

  • 8. Different alteration patterns of sub-macular choroidal thicknesses in aquaporin-4 immunoglobulin G antibodies sero-positive neuromyelitis optica spectrum diseases and isolated optic neuritis.
    Peng C, Li L, Yang M, Teng D, Wang J, Lai M, Qian H, Li H, Zhou H, Xu Q, Wei S.
    Acta Ophthalmol; 2020 Dec 02; 98(8):808-815. PubMed ID: 32657009
    [Abstract] [Full Text] [Related]

  • 9. Prevalence of anti-aquaporin 4 antibody in a diagnostic cohort of patients being investigated for possible neuromyelitis optica spectrum disorder in Western Australia.
    Fabis-Pedrini MJ, Bundell C, Wee CK, Lucas M, McLean-Tooke A, Mastaglia FL, Carroll WM, Kermode AG.
    J Neuroimmunol; 2018 Nov 15; 324():76-80. PubMed ID: 30248527
    [Abstract] [Full Text] [Related]

  • 10. Anti-aquaporin-4 titer is not predictive of disease course in neuromyelitis optica spectrum disorder: A multicenter cohort study.
    Kessler RA, Mealy MA, Jimenez-Arango JA, Quan C, Paul F, López R, Hopkins S, Levy M.
    Mult Scler Relat Disord; 2017 Oct 15; 17():198-201. PubMed ID: 29055457
    [Abstract] [Full Text] [Related]

  • 11. Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
    Sato DK, Nakashima I, Takahashi T, Misu T, Waters P, Kuroda H, Nishiyama S, Suzuki C, Takai Y, Fujihara K, Itoyama Y, Aoki M.
    Neurology; 2013 Jun 11; 80(24):2210-6. PubMed ID: 23677744
    [Abstract] [Full Text] [Related]

  • 12. Predictive Value of Serum Antibodies and Point Mutations of AQP4, AQP1 and MOG in A Cohort of Spanish Patients with Neuromyelitis Optica Spectrum Disorders.
    García-Miranda P, Morón-Civanto FJ, Martínez-Olivo MDM, Suárez-Luna N, Ramírez-Lorca R, Lebrato-Hernández L, Lamas-Pérez R, Navarro G, Abril-Jaramillo J, García-Sánchez MI, Casado-Chocán JL, Uclés-Sánchez AJ, Romera M, Echevarría M, Díaz-Sánchez M.
    Int J Mol Sci; 2019 Nov 19; 20(22):. PubMed ID: 31752329
    [Abstract] [Full Text] [Related]

  • 13. Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay.
    Hayakawa S, Mori M, Okuta A, Kamegawa A, Fujiyoshi Y, Yoshiyama Y, Mitsuoka K, Ishibashi K, Sasaki S, Hattori T, Kuwabara S.
    J Neuroimmunol; 2008 May 30; 196(1-2):181-7. PubMed ID: 18462810
    [Abstract] [Full Text] [Related]

  • 14. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.
    Guerra H, Pittock SJ, Moder KG, Fryer JP, Gadoth A, Flanagan EP.
    Mayo Clin Proc; 2018 Sep 30; 93(9):1299-1304. PubMed ID: 29655487
    [Abstract] [Full Text] [Related]

  • 15. Antiacquaporin 4 antibodies detection by different techniques in neuromyelitis optica patients.
    Fazio R, Malosio ML, Lampasona V, De Feo D, Privitera D, Marnetto F, Centonze D, Ghezzi A, Comi G, Furlan R, Martino G.
    Mult Scler; 2009 Oct 30; 15(10):1153-63. PubMed ID: 19667009
    [Abstract] [Full Text] [Related]

  • 16. Neuromyelitis optica spectrum disorders: comparison of clinical and magnetic resonance imaging characteristics of AQP4-IgG versus MOG-IgG seropositive cases in the Netherlands.
    van Pelt ED, Wong YY, Ketelslegers IA, Hamann D, Hintzen RQ.
    Eur J Neurol; 2016 Mar 30; 23(3):580-7. PubMed ID: 26593750
    [Abstract] [Full Text] [Related]

  • 17. Diagnostic utility of aquaporin-4 in the analysis of active demyelinating lesions.
    Popescu BF, Guo Y, Jentoft ME, Parisi JE, Lennon VA, Pittock SJ, Weinshenker BG, Wingerchuk DM, Giannini C, Metz I, Brück W, Shuster EA, Carter J, Boyd CD, Clardy SL, Cohen BA, Lucchinetti CF.
    Neurology; 2015 Jan 13; 84(2):148-58. PubMed ID: 25503621
    [Abstract] [Full Text] [Related]

  • 18. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica.
    Rostásy K, Mader S, Hennes EM, Schanda K, Gredler V, Guenther A, Blaschek A, Korenke C, Pritsch M, Pohl D, Maier O, Kuchukhidze G, Brunner-Krainz M, Berger T, Reindl M.
    Mult Scler; 2013 Jul 13; 19(8):1052-9. PubMed ID: 23257621
    [Abstract] [Full Text] [Related]

  • 19. Standardized method for the detection of antibodies to aquaporin-4 based on a highly sensitive immunofluorescence assay employing recombinant target antigen.
    Jarius S, Probst C, Borowski K, Franciotta D, Wildemann B, Stoecker W, Wandinger KP.
    J Neurol Sci; 2010 Apr 15; 291(1-2):52-6. PubMed ID: 20117794
    [Abstract] [Full Text] [Related]

  • 20. Quantitative assays for anti-aquaporin-4 antibody with subclass analysis in neuromyelitis optica.
    Isobe N, Yonekawa T, Matsushita T, Kawano Y, Masaki K, Yoshimura S, Fichna J, Chen S, Furmaniak J, Smith BR, Kira J.
    Mult Scler; 2012 Nov 15; 18(11):1541-51. PubMed ID: 22526930
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.